The results presented here illustrate that urinary metabolomics may be useful for detecting early-stage breast and ovarian cancer.
No takes yet. Share an insight, caveat, or question.
Slupsky et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: